EPS for Medical Properties Trust, Inc. (MPW) Expected At $0.34

September 30, 2018 - By Megan Stone

Investors sentiment increased to 1.31 in Q2 2018. Its up 0.21, from 1.1 in 2018Q1. It increased, as 26 investors sold Medical Properties Trust, Inc. shares while 88 reduced holdings. 30 funds opened positions while 119 raised stakes. 271.73 million shares or 1.45% less from 275.73 million shares in 2018Q1 were reported.
Sg Americas Securities Limited Liability holds 254,674 shares. Geode Cap Management Ltd Llc invested in 0.02% or 3.57M shares. Miles Cap Inc reported 0.45% of its portfolio in Medical Properties Trust, Inc. (NYSE:MPW). Raymond James Tru Na accumulated 12,916 shares. Focused Wealth Management holds 0% or 400 shares in its portfolio. Paloma Prtn invested 0.03% in Medical Properties Trust, Inc. (NYSE:MPW). Jpmorgan Chase & holds 1.68 million shares. City Holdg Com has 0.01% invested in Medical Properties Trust, Inc. (NYSE:MPW) for 1,591 shares. Rafferty Asset Mgmt Ltd Limited Liability Company holds 0.02% or 109,409 shares in its portfolio. State Street Corp reported 11.86M shares or 0.01% of all its holdings. Huntington Bancorp has 0% invested in Medical Properties Trust, Inc. (NYSE:MPW). Balyasny Asset Mgmt Llc has invested 0% in Medical Properties Trust, Inc. (NYSE:MPW). Piedmont Inv owns 141 shares or 0% of their US portfolio. Brinker Capital Incorporated has 0.02% invested in Medical Properties Trust, Inc. (NYSE:MPW). Naples Glob Ltd reported 20,480 shares.

Since March 27, 2018, it had 0 buys, and 2 sales for $1.72 million activity. Another trade for 116,216 shares valued at $1.46 million was made by Aldag Edward K JR on Tuesday, March 27. McLean Emmett E had sold 100,000 shares worth $1.49 million on Wednesday, August 22.

Analysts expect Medical Properties Trust, Inc. (NYSE:MPW) to report $0.34 EPS on November, 1.They anticipate $0.01 EPS change or 3.03 % from last quarter’s $0.33 EPS. MPW’s profit would be $124.07M giving it 10.96 P/E if the $0.34 EPS is correct. After having $0.36 EPS previously, Medical Properties Trust, Inc.’s analysts see -5.56 % EPS growth. The stock increased 3.11% or $0.45 during the last trading session, reaching $14.91. About 2.87 million shares traded or 56.11% up from the average. Medical Properties Trust, Inc. (NYSE:MPW) has risen 10.64% since September 30, 2017 and is uptrending. It has underperformed by 4.98% the S&P500.

Medical Properties Trust, Inc. (NYSE:MPW) Ratings Coverage

Among 2 analysts covering Medical Properties Trust (NYSE:MPW), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Medical Properties Trust had 2 analyst reports since May 31, 2018 according to SRatingsIntel. The rating was downgraded by Jefferies on Tuesday, July 17 to “Hold”. Wells Fargo maintained the stock with “Underperform” rating in Thursday, May 31 report.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. The company has market cap of $5.44 billion. MPT??s financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. It has a 15.68 P/E ratio. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities.

More news for Medical Properties Trust, Inc. (NYSE:MPW) were recently published by: Seekingalpha.com, which released: “Shining The Light On Medical Properties Trust” on September 22, 2018. Fool.com‘s article titled: “3 High-Yield Healthcare Stocks Perfect for Retirement” and published on September 22, 2018 is yet another important article.

Medical Properties Trust, Inc. (NYSE:MPW) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: